Literature DB >> 14641151

Iris colour, ethnic origin and progression of age-related macular degeneration.

Caroline M Nicolas1, Luba D Robman, Gabriella Tikellis, Peter N Dimitrov, Adam Dowrick, Robyn H Guymer, Catherine A McCarty.   

Abstract

AIM: To investigate the relationship between iris colour, ethnic origin and the progression of age-related macular degeneration (AMD).
METHODS: Participants were recruited from the population-based Melbourne Visual Impairment Project or the prospective, randomized, double-masked Vitamin E, Cataract and Age-Related Macular Degeneration study. From these two cohorts, 171 participants aged between 52 and 93 years who were identified as having early AMD features at their baseline examination (1992-1995) were followed for an average of 6.8 years (until 2001) to determine the progression rate of early AMD. The participants' iris colour was categorized as light, intermediate or dark. Ethnic origin was categorized as Anglo-Saxon or non-Anglo-Saxon, according to the participants' grandparents' country of birth.
RESULTS: In total, 53 (31%) of the 171 participants showed signs of AMD progression. Participants with light iris colour had twofold the risk of AMD progression of those with dark or intermediate iris colours, although the age-adjusted and multivariate-adjusted associations were not significant (both P = 0.13). Age-adjusted and multivariate comparisons of Anglo-Saxon ethnic origin to non-Anglo-Saxon ethnic origin showed a noticeable but non-significant association with progression of AMD (P= 0.22 and P= 0.14, respectively).
CONCLUSION: Individuals with light iris colour or of Anglo-Saxon ethnic origin had a strong tendency to greater progression of AMD. A larger sample is required to confirm these clinically important, but statistically non-significant, associations.

Entities:  

Mesh:

Year:  2003        PMID: 14641151     DOI: 10.1046/j.1442-9071.2003.00711.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  8 in total

1.  Zinc uptake and storage: the role of fundus pigmentation.

Authors:  Despina Kokkinou; Haino Uwe Kasper; Tobias Schwarz; Karl Ulrich Bartz-Schmidt; Ulrich Schraermeyer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-10-20       Impact factor: 3.117

Review 2.  Risk factors and biomarkers of age-related macular degeneration.

Authors:  Nathan G Lambert; Hanan ElShelmani; Malkit K Singh; Fiona C Mansergh; Michael A Wride; Maximilian Padilla; David Keegan; Ruth E Hogg; Balamurali K Ambati
Journal:  Prog Retin Eye Res       Date:  2016-05-06       Impact factor: 21.198

3.  Iris color and associated pathological ocular complications: a review of epidemiologic studies.

Authors:  Hong-Peng Sun; Yi Lin; Chen-Wei Pan
Journal:  Int J Ophthalmol       Date:  2014-10-18       Impact factor: 1.779

Review 4.  Clinical application of ultra-widefield fundus autofluorescence.

Authors:  Amin Xu; Changzheng Chen
Journal:  Int Ophthalmol       Date:  2020-10-11       Impact factor: 2.031

Review 5.  Clinical applications of fundus autofluorescence in retinal disease.

Authors:  Madeline Yung; Michael A Klufas; David Sarraf
Journal:  Int J Retina Vitreous       Date:  2016-04-08

Review 6.  Neovascular Macular Degeneration: A Review of Etiology, Risk Factors, and Recent Advances in Research and Therapy.

Authors:  Arunbalaji Pugazhendhi; Margaret Hubbell; Pooja Jairam; Balamurali Ambati
Journal:  Int J Mol Sci       Date:  2021-01-25       Impact factor: 5.923

7.  Estimated prevalence and risk factor for age-related maculopathy.

Authors:  Mi In Roh; Ji Hyun Kim; Suk Ho Byeon; Hyoung Jun Koh; Sung Chul Lee; Oh Woong Kwon
Journal:  Yonsei Med J       Date:  2008-12-31       Impact factor: 2.759

8.  Distribution of iris color and its association with ocular diseases in a rural population of Iran.

Authors:  Hassan Hashemi; Reza Pakzad; Abbasali Yekta; Fereshteh Shokrollahzadeh; Hadi Ostadimoghaddam; Hassan Mahboubipour; Mehdi Khabazkhoob
Journal:  J Curr Ophthalmol       Date:  2018-05-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.